Deciphera Pharmaceuticals Inc (DCPH)
25.46
+0.02
(+0.06%)
USD |
NASDAQ |
May 17, 16:00
25.46
0.00 (0.00%)
After-Hours: 20:00
Deciphera Pharmaceuticals Price to Book Value: 6.966 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 6.966 |
| May 16, 2024 | 6.964 |
| May 15, 2024 | 6.964 |
| May 14, 2024 | 6.961 |
| May 13, 2024 | 6.955 |
| May 10, 2024 | 6.939 |
| May 09, 2024 | 6.942 |
| May 08, 2024 | 6.942 |
| May 07, 2024 | 6.944 |
| May 06, 2024 | 6.942 |
| May 03, 2024 | 6.603 |
| May 02, 2024 | 6.603 |
| May 01, 2024 | 6.598 |
| April 30, 2024 | 6.574 |
| April 29, 2024 | 6.577 |
| April 26, 2024 | 3.812 |
| April 25, 2024 | 3.689 |
| April 24, 2024 | 3.804 |
| April 23, 2024 | 3.817 |
| April 22, 2024 | 3.790 |
| April 19, 2024 | 3.814 |
| April 18, 2024 | 3.699 |
| April 17, 2024 | 3.826 |
| April 16, 2024 | 3.858 |
| April 15, 2024 | 3.873 |
| Date | Value |
|---|---|
| April 12, 2024 | 3.912 |
| April 11, 2024 | 4.034 |
| April 10, 2024 | 4.058 |
| April 09, 2024 | 4.066 |
| April 08, 2024 | 3.902 |
| April 05, 2024 | 3.988 |
| April 04, 2024 | 3.936 |
| April 03, 2024 | 3.975 |
| April 02, 2024 | 3.949 |
| April 01, 2024 | 4.097 |
| March 31, 2024 | |
| March 28, 2024 | 3.622 |
| March 27, 2024 | 3.495 |
| March 26, 2024 | 3.412 |
| March 25, 2024 | 3.523 |
| March 22, 2024 | 3.507 |
| March 21, 2024 | 3.569 |
| March 20, 2024 | 3.626 |
| March 19, 2024 | 3.447 |
| March 18, 2024 | 3.419 |
| March 15, 2024 | 3.590 |
| March 14, 2024 | 3.663 |
| March 13, 2024 | 3.680 |
| March 12, 2024 | 3.705 |
| March 11, 2024 | 3.808 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.184
Minimum
Nov 29 2021
8.546
Maximum
Aug 28 2019
3.800
Average
3.699
Median
Apr 18 2024
Price to Book Value Benchmarks
| Bristol-Myers Squibb Co | 5.413 |
| Dynavax Technologies Corp | 2.351 |
| Gilead Sciences Inc | 4.810 |
| Esperion Therapeutics Inc | -- |
| SINTX Technologies Inc | 1.051 |
Price to Book Value Related Metrics
| PS Ratio | 12.55 |
| Price | 25.46 |
| Earnings Yield | -8.68% |
| Market Cap | 2.202B |